AACR VIRTUAL SPECIAL CONFERENCE
ARTIFICIAL INTELLIGENCE, DIAGNOSIS, AND IMAGING
This AACR Virtual Special Conference will address the latest developments in artificial intelligence, diagnosis, and imaging. International experts will present their latest research on artificial intelligence and machine learning in pathology, radiomics, multiplex imaging, genome biology, and clinical genomics. Sessions will also address clinical Implementation of machine learning models in oncology; development of data resources, data standards, access policy, reproducibility, and benchmarking; and challenges and opportunities in machine learning algorithms for cancer research. This conference will provide a unique opportunity for exchanges between a wide array of researchers, including basic scientists, computer scientists, translational researchers, information scientists, and clinical researchers. Make plans now to participate in this exciting conference.
Date
January 13 - 14, 2021
3pm ET
Virtual Conference
Latest News
Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to CTX001, an investigational, autologous, ex vivo CRISPR/Cas9 gene-edited therapy for the treatment of transfusion-dependent beta thalassemia (TDT).
LEARN MOREPfizer Acquires Amplyx Pharmaceuticals
Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.
LEARN MOREJanux Therapeutics Closes $125 Million Series B Financing to Advance Next Generation T Cell Engager Immunotherapies into Clinical Trials
Janux Therapeutics today announced the closing of a $125 million Series B financing led by RA Capital Management and joined by new investors BVF Partners L.P., EcoR1 Capital, Hartford HealthCare Endowment, Janus Henderson Investors, Logos Capital, Samsara BioCapital and Surveyor Capital (a Citadel company).
LEARN MORE